InsidersTradesSigma
Discover the complete record of transactions filed by Paulson Richard A., Chairman & CEO. Insider active across 1 companies, notably Karyopharm Therapeutics Inc.. Aggregated, 7 filings have been logged. Total volume traded: €17k. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
7 of 7 declarations
Richard A. Paulson serves as President and CEO of Karyopharm Therapeutics Inc. He leads the operations of the company, guiding its strategy and growth. His leadership is essential in achieving organizational objectives.